640
Views
8
CrossRef citations to date
0
Altmetric
Article Addendum

Myosin I

A new pip3 effector in chemotaxis and phagocytosis

&
Pages 294-296 | Published online: 01 May 2012

References

  • Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001; 2:123 - 8; http://dx.doi.org/10.1038/84219; PMID: 11175804
  • Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001; 345:833 - 5; http://dx.doi.org/10.1056/NEJM200109133451113; PMID: 11556308
  • Braunersreuther V, Mach F. Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches?. Cell Mol Life Sci 2006; 63:2079 - 88; http://dx.doi.org/10.1007/s00018-006-6127-2; PMID: 16952057
  • Mrass P, Weninger W. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Immunol Rev 2006; 213:195 - 212; http://dx.doi.org/10.1111/j.1600-065X.2006.00433.x; PMID: 16972905
  • Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE. Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 2007; 12:143 - 52; http://dx.doi.org/10.1007/s10911-007-9046-4; PMID: 17557195
  • Affolter M, Weijer CJ. Signaling to cytoskeletal dynamics during chemotaxis. Dev Cell 2005; 9:19 - 34; http://dx.doi.org/10.1016/j.devcel.2005.06.003; PMID: 15992538
  • Rørth P. Whence directionality: guidance mechanisms in solitary and collective cell migration. Dev Cell 2011; 20:9 - 18; http://dx.doi.org/10.1016/j.devcel.2010.12.014; PMID: 21238921
  • Bagorda A, Parent CA. Eukaryotic chemotaxis at a glance. J Cell Sci 2008; 121:2621 - 4; http://dx.doi.org/10.1242/jcs.018077; PMID: 18685153
  • Nishio M, Watanabe K, Sasaki J, Taya C, Takasuga S, Iizuka R, et al. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 2007; 9:36 - 44; http://dx.doi.org/10.1038/ncb1515; PMID: 17173042
  • Subramanian KK, Jia Y, Zhu D, Simms BT, Jo H, Hattori H, et al. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood 2007; 109:4028 - 37; http://dx.doi.org/10.1182/blood-2006-10-055319; PMID: 17202315
  • Iijima M, Devreotes P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 2002; 109:599 - 610; http://dx.doi.org/10.1016/S0092-8674(02)00745-6; PMID: 12062103
  • Funamoto S, Meili R, Lee S, Parry L, Firtel RA. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 2002; 109:611 - 23; http://dx.doi.org/10.1016/S0092-8674(02)00755-9; PMID: 12062104
  • Parent CA, Blacklock BJ, Froehlich WM, Murphy DB, Devreotes PN. G protein signaling events are activated at the leading edge of chemotactic cells. Cell 1998; 95:81 - 91; http://dx.doi.org/10.1016/S0092-8674(00)81784-5; PMID: 9778249
  • Iijima M, Huang YE, Devreotes P. Temporal and spatial regulation of chemotaxis. Dev Cell 2002; 3:469 - 78; http://dx.doi.org/10.1016/S1534-5807(02)00292-7; PMID: 12408799
  • Iijima M, Huang YE, Luo HR, Vazquez F, Devreotes PN. Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J Biol Chem 2004; 279:16606 - 13; http://dx.doi.org/10.1074/jbc.M312098200; PMID: 14764604
  • Meili R, Ellsworth C, Lee S, Reddy TB, Ma H, Firtel RA. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J 1999; 18:2092 - 105; http://dx.doi.org/10.1093/emboj/18.8.2092; PMID: 10205164
  • Stephens L, Milne L, Hawkins P. Moving towards a better understanding of chemotaxis. Current biology: CB 2008; 18:R485-94.
  • King JS, Insall RH. Chemotaxis: finding the way forward with Dictyostelium. Trends Cell Biol 2009; 19:523 - 30; http://dx.doi.org/10.1016/j.tcb.2009.07.004; PMID: 19733079
  • Zhang P, Wang Y, Sesaki H, Iijima M. Proteomic identification of phosphatidylinositol (3,4,5) triphosphate-binding proteins in Dictyostelium discoideum. Proc Natl Acad Sci U S A 2010; 107:11829 - 34; http://dx.doi.org/10.1073/pnas.1006153107; PMID: 20547830
  • Chen CL, Wang Y, Sesaki H, Iijima M, Myosin I. Myosin I links PIP3 signaling to remodeling of the actin cytoskeleton in chemotaxis. Sci Signal 2012; 5:ra10; http://dx.doi.org/10.1126/scisignal.2002446; PMID: 22296834
  • de la Roche MA, Côté GP. Regulation of Dictyostelium myosin I and II. Biochim Biophys Acta 2001; 1525:245 - 61; http://dx.doi.org/10.1016/S0304-4165(01)00110-6; PMID: 11257438
  • Kim SV, Flavell RA. Myosin I: from yeast to human. Cell Mol Life Sci 2008; 65:2128 - 37; http://dx.doi.org/10.1007/s00018-008-7435-5; PMID: 18344022
  • McConnell RE, Tyska MJ. Leveraging the membrane—cytoskeleton interface with myosin-1. Trends Cell Biol 2010; 20:418 - 26; http://dx.doi.org/10.1016/j.tcb.2010.04.004; PMID: 20471271
  • Krugmann S, Anderson KE, Ridley SH, Risso N, McGregor A, Coadwell J, et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell 2002; 9:95 - 108; http://dx.doi.org/10.1016/S1097-2765(02)00434-3; PMID: 11804589